Did you know that there are more than 7,000 rare diseases known to date? Defined by Congress under the Orphan Drug Act of 1983, the definition of rare disease in the United States is a condition that affects fewer than 200,000 people. In Europe, rare disease is defined as affecting fewer than 1 in 2000 […]
Cancer may have started the fight, but it’s time we finish it. Every one of us knows of a family member, friend, or colleague who has been affected, or we may have been personally affected by cancer. Our goal at MedSource is bigger than one person, or one even company. Our goal is to help save […]
In 2019, approximately 13,170 new cases of invasive cervical cancer will be diagnosed. From these cases, nearly 4,300 women will die from the disease. Once the most common cause of cancer death for American women, cervical cancer now ranks 14th in frequency due to the increased use of the Pap test. Most cases of cervical […]
Within the highly competitive climate of drug development, a creative, strategic and data-driven clinical development plan is essential for navigating the clinical trial landscape. When attempting to deliver a program quickly and effectively, it can be easy to miss opportunities with limited resources, infrastructure, and technological challenges. It is imperative that a clinical research partner […]
Solid growth and expansion for Houston-based CRO furthers drug development for small & mid-sized biotech HOUSTON (October 25, 2018) – The accelerating growth track of Houston-based MedSource was recognized again recently when Biospace named the company as the # 4 fastest growing private life science company in the United States. The Biospace ranking was determined […]
Each year, approximately 300,000 new cases of cancer affect children under the age of 19 worldwide. More than 15,000 of these children are located in the United States alone. Despite the statistics, pediatric cancer researchers and doctors continue to face challenges. Only three new drugs have been approved by the FDA specifically developed to treat […]
Clinical trials are a cornerstone in the goal of curing, managing, or even eradicating the illnesses and conditions that millions of people face every day. In this particular trial, outlined in our latest case study, we worked with a very rare and complicated patient population. Due to the complexity and potential complications that patients with […]
MedSource lands at # 4 on the list of the top 15 fastest-growing private life science companies in the US! Check out the full article from BioSpace here. Thank you to BioSpace for this exciting ranking and thank you to all of our customers who trust us with their clinical trials! And a very special thanks […]
We are excited and honored for MedSource to make the 2018 Inc. 5000 list at #1363. This adds to our Hall of Fame status as a 6x honoree. Thank you to all of our dedicated and hardworking employees and our customers that partner with us to help us earn this honor. Check out this link […]
Senior Project Manager, Alicia Williams, gave an informative and topical presentation on “Optimizing Site Start-Up in Oncology Trials” at the Annual Clinical Operations in Oncology Trials East Coast Conference, hosted by Arena. Alicia’s presentation includes useful resources including typical challenges faced in study start-up, complexities of oncology trials, best practices, as well as real study […]
Surveys of real users of CRO services lead to multiple honors Houston, TEXAS (July 22, 2015) – Recent awards demonstrate that the MedSource approach to clinical research is getting notice among pharmaceutical and biotech companies using CRO services. Honors include a total of five 2015 CRO Leadership Awards and being named one of the Top […]
HOUSTON, Oct. 27, 2016 /PRNewswire/ — Houston-based MedSource is celebrating three years of remarkable growth with awards and industry recognition, even as it prepares for a five-year trajectory that would see it, once again, double in size. The clinical research organization (CRO), which currently has 115 employees, experienced 260 percent revenue growth over the course of two years, starting in […]
Acquisition of new unit positions CRO to support biotech in the European market, deliver clients full, end-to-end biometrics services HOUSTON, June 13, 2017 /PRNewswire/ — Houston-based MedSource expanded its clinical development repertoire, acquiring the data services division of biometrics and technology company Datatrial in early 2017. The deal both strengthens MedSource’s position as a full-service clinical research organization (CRO) and paves the […]
We are honored to have made the 2017 Inc. 5000 list at #1293. This marks our 5th time on the list, earning us a spot in the Hall of Fame! We are grateful for the hard work and dedication of our employees who helped us to earn this honor! See full list here.
Addition of early clinical development services, new Boston location spurs CRO growth HOUSTON, Sept. 14, 2017 /PRNewswire/ — Houston-based Clinical Research Organization (CRO) MedSource is growing its service-offering to include the early stages of clinical development and pipeline planning through Investigational New Drug (IND) submissions. The service, rarely offered by CROs, will be provided by a new department – Scientific […]